Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does viloxazine have epileptogenic properties?

J G Edwards, M Glen-Bott

    Journal of Neurology, Neurosurgery, and Psychiatry
    |September 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The role of lymphocytic CD5 in the effects of ethanol on mesolimbic circuitry and ethanol consumption behavior.

    Brain, behavior, and immunity·2026
    Same author

    Radiological insights into costal margin rupture injuries: patterns of associated rib and costal cartilage fractures.

    European journal of trauma and emergency surgery : official publication of the European Trauma Society·2025
    Same author

    High throughput screen of small molecules as potential countermeasures to galactic cosmic radiation induced cellular dysfunction.

    Life sciences in space research·2022
    Same author

    The role of imaging in malignant pleural mesothelioma: an update after the 2018 BTS guidelines.

    Clinical radiology·2020
    Same author

    Reciprocal Relationships: the Genetic Counselor-Patient Relationship Following a Life-Limiting Prenatal Diagnosis.

    Journal of genetic counseling·2016
    Same author

    Myocardial Mitochondria at the Intersection of Health and Disease.

    Journal of clinical & experimental cardiology·2016
    Same journal

    Diagnostic accuracy of a two-cut-off approach using the FAQ/MMSE ratio and FAQ for clinical preselection of patients for anti-amyloid therapy.

    Journal of neurology, neurosurgery, and psychiatry·2026
    Same journal

    Cancer risk and mortality in patients with multiple sclerosis in Finland: a retrospective population-based cohort study.

    Journal of neurology, neurosurgery, and psychiatry·2026
    Same journal

    Visuospatial working memory in Huntington's disease: behavioural and structural brain correlates.

    Journal of neurology, neurosurgery, and psychiatry·2026
    Same journal

    Characteristics and outcomes in electric scooter-related traumatic brain injuries in Helsinki.

    Journal of neurology, neurosurgery, and psychiatry·2026
    Same journal

    Chronological ageing and ovarian reserve in MS: insights from anti-Müllerian hormone and disability progression.

    Journal of neurology, neurosurgery, and psychiatry·2026
    Same journal

    Durable fluoropolymer drug-eluting stent versus bare-metal stent for the prevention of intracranial in-stent restenosis.

    Journal of neurology, neurosurgery, and psychiatry·2026
    See all related articles

    Viloxazine is an antidepressant that may cause seizures in some patients, but evidence suggests it is less epileptogenic than traditional antidepressants. It may be suitable for epileptic patients needing antidepressant treatment.

    Area of Science:

    • Pharmacology
    • Clinical Neurology

    Background:

    • Viloxazine is an antidepressant medication.
    • Concerns have been raised regarding its potential to cause seizures.

    Observation:

    • A review of six UK cases and two Japanese cases of seizures during viloxazine treatment was conducted.
    • A causal link between viloxazine and seizures was probable in only two of the reported cases.

    Findings:

    • Animal studies and clinical trials indicate viloxazine has anticonvulsant properties, not epileptogenic ones.
    • Viloxazine appears less likely to induce seizures compared to conventional tricyclic antidepressants.

    Implications:

    • Viloxazine may be a safer antidepressant option for patients with epilepsy.

    Related Experiment Videos

  • Further research is warranted to fully understand viloxazine's neurological effects.